Shoulder Instability Trial Comparing Arthroscopic Stabilization Benefits Compared With Latarjet Procedure Evaluation

NCT03585491 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 86

Last updated 2025-09-26

No results posted yet for this study

Summary

The primary objective of the pilot study is to assess the feasibility of a definitive trial to determine the effect of arthroscopic capsuloligamentous repair (Bankart + Remplissage) vs. coracoid transfer (Latarjet procedure) on recurrent dislocation rates and functional outcomes over a 24-month period.

Conditions

  • Shoulder Dislocation
  • Sport Injuries
  • Shoulder
  • Anterior Dislocation

Interventions

PROCEDURE

Latarjet Procedure

Participants will undergo open or arthroscopic Latarjet procedure.

PROCEDURE

Bankart + Remplissage Procedure

Participants will undergo arthroscopic stabilization.

Sponsors & Collaborators

  • St. Joseph's Healthcare Hamilton

    collaborator OTHER
  • University of Western Ontario, Canada

    collaborator OTHER
  • The Ottawa Hospital

    collaborator OTHER
  • Pan Am Clinic

    collaborator OTHER
  • University of Colorado, Denver

    collaborator OTHER
  • Queen's University

    collaborator OTHER
  • Sunnybrook Health Sciences Centre

    collaborator OTHER
  • Boston University

    collaborator OTHER
  • Deventer Ziekenhuis

    collaborator OTHER
  • Banff Sport Medicine Foundation

    collaborator OTHER
  • McMaster University

    collaborator OTHER
  • Brantford General Hospital

    collaborator UNKNOWN
  • London Health Sciences Centre

    collaborator OTHER
  • Parc de Salut Mar

    collaborator OTHER
  • Hospital Universitari de Bellvitge

    collaborator OTHER
  • Hospital de Terrassa

    collaborator OTHER
  • Hospital Mutua de Terrassa

    collaborator OTHER
  • Pontificia Universidad Catolica de Chile

    collaborator OTHER
  • Endeavor Health

    collaborator OTHER
  • Medstar Health Research Institute

    collaborator OTHER
  • Hospital Universitari Vall d'Hebron Research Institute

    collaborator OTHER
  • Moin Khan

    lead OTHER

Principal Investigators

  • Moin Khan, MD · McMaster University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-07-01
Primary Completion
2026-12-01
Completion
2027-12-01

Countries

  • Canada

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03585491 on ClinicalTrials.gov